口服補液鹽（ORS）全球市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計口服補液鹽 (ORS) 市場規模將從 2025 年的 36.1 億美元成長到 2034 年的 84.8 億美元，2026 年至 2034 年的複合年成長率為 9.97%。

隨著對有效補液療法的需求不斷成長，口服補液鹽（ORS）市場預計將迎來顯著成長，尤其是在腹瀉和其他胃腸道疾病導致脫水高發的地區。 ORS 是一種便捷且經濟有效的補充體液和電解質的方案，使其成為公共衛生措施的重要組成部分。人們對補液重要性的認知不斷提高，以及 ORS 在預防嚴重脫水方面的有效性日益凸顯，正在推動全球對 ORS 的需求。

技術創新在塑造口服補液鹽（ORS）市場的未來方面發揮關鍵作用。配方科學的創新，包括風味型和即飲型ORS產品的開發，正在提高患者的接受度和使用便利性，尤其是在兒童群體中。此外，包裝技術和分銷方式的進步也改善了服務不足地區取得ORS的途徑。隨著製造商持續加大研發投入，我們預期ORS將在包括醫院、診所和社區健康計畫在內的各種醫療機構中得到更廣泛的應用。

此外，人們對預防性醫療保健和教育日益成長的興趣正在推動口服補液鹽（ORS）市場的成長。隨著醫療保健機構和組織致力於提高人們對脫水的認知並推廣ORS的益處，對教育資源和社區宣傳計畫的需求也日益成長。這一趨勢促使製造商、醫療專業人員和公共衛生組織加強合作，共同推動幫助個人和家庭有效管理水分的各項工作。隨著市場的不斷發展，技術、教育和社區參與的整合將是成功的關鍵。

目錄

第1章 引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 繪製滲透率和成長前景圖
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 市場問題
• 波特五力分析
• PESTLE分析

4. 全球口服補液鹽 (ORS) 市場依產品類型分類

• 市場分析、洞察與預測
• 藥片
• 粉末
• 解決方案

5. 全球口服補液鹽 (ORS) 市場按應用領域分類

• 市場分析、洞察與預測
• 醫院
• 診所
• 居家照護
• 其他

6. 全球口服補液鹽 (ORS) 市場依分銷管道分類

• 市場分析、洞察與預測
• 網路商店
• 藥局
• 超級市場和大賣場
• 專賣店
• 其他

7. 全球口服補液鹽（ORS）市場（依最終用戶分類）

• 市場分析、洞察與預測
• 嬰兒
• 孩子們
• 成人
• 老年人

8. 全球口服補液鹽（ORS）市場（依地區分類）

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商格局（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Johnson & Johnson
  • Sanofi
  • Pfizer Inc
  • Abbott Laboratories
  • GlaxoSmithKline Plc
  • Bayer AG
  • Novartis AG
  • Merck & Co.Inc
  • F. Hoffmann-La Roche Ltd
  • Cipla Limited
  • Sun Pharmaceutical Industries Ltd
  • Daiichi Sankyo Company, Limited
  • Reckitt Benckiser Group Plc
  • NestlAfA（C）SA
  • Baxter International Inc

The Oral Rehydration Solution (ORS) Market size is expected to reach USD 8.48 Billion in 2034 from USD 3.61 Billion (2025) growing at a CAGR of 9.97% during 2026-2034.

The Oral Rehydration Solution (ORS) Market is poised for significant growth as the demand for effective rehydration therapies increases, particularly in regions with high incidences of dehydration due to diarrhea and other gastrointestinal disorders. ORS is a simple and cost-effective solution that helps replenish lost fluids and electrolytes, making it a critical component of public health initiatives. The rising awareness of the importance of hydration and the effectiveness of ORS in preventing severe dehydration is driving the demand for these solutions globally.

Technological advancements are playing a crucial role in shaping the future of the ORS market. Innovations in formulation science, including the development of flavored and ready-to-use ORS products, are enhancing the acceptability and ease of use for patients, particularly children. Additionally, advancements in packaging and distribution methods are improving access to ORS in underserved areas. As manufacturers continue to invest in research and development, the ORS market is likely to see increased adoption across various healthcare settings, including hospitals, clinics, and community health programs.

Moreover, the growing emphasis on preventive healthcare and education is influencing the ORS market's growth trajectory. As healthcare providers and organizations focus on promoting awareness of dehydration and the benefits of ORS, there is a rising demand for educational resources and community outreach programs. This trend is driving collaboration between manufacturers, healthcare professionals, and public health agencies to develop initiatives that empower individuals and families to manage hydration effectively. As the market continues to evolve, the integration of technology, education, and community engagement will be key drivers of success.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Tablets
• Powders
• Solutions

By Application

• Hospitals
• Clinics
• Home Care
• Others

By Distribution Channel

• Online Stores
• Pharmacies
• Supermarkets/Hypermarkets
• Specialty Stores
• Others

By End-User

• Infants
• Children
• Adults
• Elderly

COMPANIES PROFILED

• Johnson Johnson, Sanofi, Pfizer Inc, Abbott Laboratories, GlaxoSmithKline plc, Bayer AG, Novartis AG, Merck Co, Inc, F HoffmannLa Roche Ltd, Cipla Limited, Sun Pharmaceutical Industries Ltd, Daiichi Sankyo Company, Limited, Reckitt Benckiser Group plc, Nestl SA, Baxter International Inc

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Tablets Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Powders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Solutions Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Home Care Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Distribution Channel
• 6.2. Online Stores Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Supermarkets/Hypermarkets Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Specialty Stores Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET: BY END-USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-user
• 7.2. Infants Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Children Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Adults Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Elderly Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product Type
  • 8.2.2 By Application
  • 8.2.3 By Distribution Channel
  • 8.2.4 By End-user
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product Type
  • 8.3.2 By Application
  • 8.3.3 By Distribution Channel
  • 8.3.4 By End-user
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product Type
  • 8.4.2 By Application
  • 8.4.3 By Distribution Channel
  • 8.4.4 By End-user
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product Type
  • 8.5.2 By Application
  • 8.5.3 By Distribution Channel
  • 8.5.4 By End-user
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product Type
  • 8.6.2 By Application
  • 8.6.3 By Distribution Channel
  • 8.6.4 By End-user
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL ORAL REHYDRATION SOLUTION (ORS) INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Johnson & Johnson
  • 10.2.2 Sanofi
  • 10.2.3 Pfizer Inc
  • 10.2.4 Abbott Laboratories
  • 10.2.5 GlaxoSmithKline Plc
  • 10.2.6 Bayer AG
  • 10.2.7 Novartis AG
  • 10.2.8 Merck & Co.Inc
  • 10.2.9 F. Hoffmann-La Roche Ltd
  • 10.2.10 Cipla Limited
  • 10.2.11 Sun Pharmaceutical Industries Ltd
  • 10.2.12 Daiichi Sankyo Company, Limited
  • 10.2.13 Reckitt Benckiser Group Plc
  • 10.2.14 NestlAfA(C) S.A
  • 10.2.15 Baxter International Inc